Profile cover photo
Profile photo
Global Integrated Reimbursement Services, Inc.
6 followers
6 followers
About
Communities and Collections
View all
Posts

Post has attachment
Following an investigation by USA Today Network-Kaiser Health News, CMS is considering a proposal that will impact senior patients. Commenting on the new proposal ends on September 24. GIRS has previous experience assisting with commenting on moving inpatient procedures to the outpatient setting. Does your medical device company need help reviewing inpatient procedures that need to be moved to the outpatient setting? Are you considering how your payment or reimbursement options may be impacted? GIRS' blog has all the details regarding this issue: http://reimbursementquestions.com/medicare-reviews-seniors-spine-operations-at-surgery-centers/
Photo

Post has attachment
Anthem has overturned a large number of denied claims for ER patients in 2017. Read today's blog post to find out why this has happened, what it means for you, and how GIRS can help with reimbursement and denied claims in payers' appeal processes:
http://reimbursementquestions.com/appealing-can-eventually-successfully-overcome-claims-denials-and-girs-can-help/
Photo

Post has attachment
CMS published new proposed rules that addresses changes to telehealth coding and payment on July 12, 2018. The commenting period ends on September 10. Not sure where to begin? Contact GIRS for support in commenting and don't forget to read more details on today's blog post:
http://reimbursementquestions.com/cms-proposes-telehealth-coding-and-payment-changes-for-cy-2019/
Photo

Post has attachment
Our client had a biologic billed with an unlisted J code. Competitors and coding experts were recommending that this type of product be billed with incorrect codes. This situation was critical to remedy, as the use of incorrect codes could have led to an increased risk of audits for the providers. Read on today's blog how GIRS solved the situation, allowing for our client’s accounts to submit clean claims:
http://reimbursementquestions.com/prevention-of-inappropriate-billing-leads-to-the-assignment-of-a-specific-code-for-a-biologic/
Photo

Post has attachment
Thanks to the efforts of the GIRS PAC® Team, over 4 million New Yorker's now have access to a breakthrough medical device. Find out how (and where to start for coverage) on today's blog:
http://reimbursementquestions.com/girs-pac-team-garners-positive-coverage-and-greater-market-access-for-over-four-million-patients-in-new-york/
Photo

Post has attachment
Due to the diligence of GIRS' Payer Advocacy Compass® team, an ambiguous medical policy was clarified and positive coverage was obtained for a novel medical device with an important payer in the Northeastern US. This work resulted in increased patient access by 5 million covered lives. Read our case study: https://bit.ly/2Lm8VeZ
to learn more about how our team achieved this goal for one of our clients, and to understand how we can similarly assist you to accomplish your market uptake goals for your pharmaceuticals, medical devices, biologics, and diagnostics.
Photo

Post has attachment
On July 2, 2018, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule [CMS-1689-P] outlining proposed Calendar Year (CY) 2019 Medicare payment updates and proposed quality reporting changes for home health agencies (HHAs), and proposed case-mix methodology refinements and a change in the home health unit of payment from 60 days to 30 days for CY 2020.

To understand the impact of these changes on your medical technology reimbursement or for commenting support, contact us:
http://reimbursementquestions.com/cms-proposes-calendar-year-2019-and-2020-payment-and-policy-changes-for-home-health-agencies-and-home-infusion-therapy-suppliers/

Post has attachment
Read How GIRS Strategies Equipped one U.S. Manufacturer to Engage in Targeted Reimbursement Tactics for their Unique Device:
http://reimbursementquestions.com/the-girs-value-discovery-landscape-assessments-lays-the-foundation-for-market-access-for-a-unique-product
Photo

Post has attachment

GIRS is committed to increasing patient access for our clients' novel products. Recently, our Payer Advocacy Compass® team assisted a client to expand coverage for their two biologic products in North Carolina, improving patient access to more than three million commercial and Medicare advantage members in the state.

Read how our team was able to achieve these results on today's blog post:
https://bit.ly/2Kk5PbP
Photo

Post has attachment
Our Payer Advocacy Compass® team assisted a client to expand coverage for their advanced tissue-repair products in Michigan, providing access to 650,000 health plan members:
https://bit.ly/2Krbb0V

At Global Integrated Reimbursement Services, Inc., we are committed to delivering favorable market access for our clients' products. For more information on how we can support your company to achieve the same success, contact us: http://girsinc.com/contact/
Photo
Wait while more posts are being loaded